跳至主要内容
临床试验/IRCT20090901002394N50
IRCT20090901002394N50招募中3 期

Effects of vitamin D and magnesium co-supplementation on cognitive function and C-reactive protein level in patients with type 2 diabetes: A double-blind randomized placebo-control trial

Iran University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 65 years(—)
性别
All

入选标准

  • Willing to participate and signing informed consent
  • Diagnosis of diabetes by a specialist
  • Stable blood glucose level defined by HbA1C< 8.5%
  • Patients who are currently under medication therapy
  • At least 5 years history of type 2 diabetes

排除标准

  • Having severe complications of diabetes such as amputation, blindness and dialysis
  • Patients with malabsorption syndromes
  • History of stroke, transient ischemic attack and lacunar infarction
  • Patients with severe depression and anxiety, bipolar and psychosis
  • Loss of consciousness for more than 5 minutes
  • Having dementia, Parkinson's, schizophrenia, Huntington's, AIDS, HIV positive
  • Patients with chronic diseases such as liver failure, thyroid diseases and cancer.
  • Alcohol, smoking and drug use
  • Pregnant and lactating women or women who intend to become pregnant
  • Taking drugs affecting the CNS
  • Any change in the patient's medicine or its dosage during the last 3 months before the trial
  • Regular consumption of higher than RDA doses of magnesium and vitamin D supplements and other supplements during the 2 months prior to the intervention
  • Taking medicine containing magnesium more than 150 mg

研究者

相似试验

Effects of vitamin D and magnesium... | 临床试验